NervGen Pharma Statistics

Total Valuation

NervGen Pharma has a market cap or net worth of 182.95 million. The enterprise value is 170.67 million.

Market Cap	182.95M
Enterprise Value	170.67M

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	70.99M
Shares Outstanding	n/a
Shares Change (YoY)	+13.55%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	59.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	102.17
P/TBV Ratio	124.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.04.

Current Ratio	1.12
Quick Ratio	1.05
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8,460.20% and return on invested capital (ROIC) is -3,580.97%.

Return on Equity (ROE)	-8,460.20%
Return on Assets (ROA)	-95.24%
Return on Invested Capital (ROIC)	-3,580.97%
Return on Capital Employed (ROCE)	-964.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.81% in the last 52 weeks. The beta is 0.30, so NervGen Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+65.81%
50-Day Moving Average	2.12
200-Day Moving Average	1.99
Relative Strength Index (RSI)	70.81
Average Volume (20 Days)	90,714

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.33M
Pretax Income	-16.68M
Net Income	-16.68M
EBITDA	-17.29M
EBIT	-17.33M
Earnings Per Share (EPS)	-0.25

Full Income Statement

Balance Sheet

The company has 12.00 million in cash and 73,395 in debt, giving a net cash position of 11.93 million.

Cash & Cash Equivalents	12.00M
Total Debt	73,395
Net Cash	11.93M
Net Cash Per Share	n/a
Equity (Book Value)	1.79M
Book Value Per Share	0.03
Working Capital	1.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.70M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NervGen Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.55%
Shareholder Yield	-13.55%
Earnings Yield	-9.12%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a